Co-hosts Dave Franchino and Stefanie Norvaisas talk with Adam Elsesser, Chairman and CEO of Penumbra, a California-based company that develops innovative products for neurological and vascular conditions. Adam co-founded Penumbra with a physician friend in 2004. It was their second venture together, after selling their first medical device company to Boston Scientific. Adam talks about the importance of making sure the work is meaningful as a guide for all Penumbra's innovation projects. He also discusses the challenges and opportunities that have been revealed during the Covid 19 pandemic and how it's changing the way he and the company operate.